Feb 16, 2023 / NTS GMT
Annalisa Zuccotti -
Welcome, everybody, to our M2M new format, new event at BioRN. M2M stands for Member to Member. So we are here to showcase our members to other members. My name is Annalisa Zuccotti. I'm in charge of communication and events at BioRN. And today, I came to Ladenburg, at Heidelberg Pharma. And then here with Artjom, please shortly introduce yourself.
Artjom Wischnjow -
Thank you very much, Annalisa. It's great to be here and to present -- and the opportunity to present our company to the audience. So my name is Artjom Wischnjow. I'm Associate Director Business Development here at Heidelberg Pharma. Actually, I'm scientist by training and still a scientist in my heart. I studied Biotechnology at Technical University, Darmstadt, done my Ph.D. at the University Hospital in Heidelberg. After that, I joined Novartis for a couple of years and 2018, so to say, back to the roots, joined Heidelberg Pharma as a group leader in a bioanalytical department, and since 2020, I'm part of the (inaudible) team.
Annalisa Zuccotti -
Great. Thank
Heidelberg Pharma AG Corporate Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot